07 October 2024

The Groundbreaking Cancer Expert: (New Research) This Common Food Is Making Cancer Worse! Cancer Is Getting Worse Worldwide & It Might Not Be Genetic, It's Your Diet!

1Frameworks

13Insights

Frameworks in this episode

Self-Mastery5 steps

Glucose Ketone Index Monitoring

Combine blood glucose and ketones into one repeatable metabolic reading

Read →

Insights & moments

The myth-busts, hot takes, explainers, and tools worth keeping.

Myth Buster· 1

Myth Buster1:04:30

Seyfried Does Not Tell Listeners to Abandon Chemotherapy

When Bartlett asks directly whether newly diagnosed patients should reject chemotherapy, Seyfried says he is not telling them that. He argues instead that nutritional ketosis might allow lower-dose chemotherapy or support surgery, radiation, and immunotherapy in selected settings, citing colleagues in Turkey. The transcript supplies no trial details sufficient to establish those combination claims.

Seyfried explicitly stops short of telling patients to refuse chemotherapy
He distinguishes his criticism of brain radiation from other cancers
He proposes weakening or shrinking tumours before standard interventions
Treatment choices remain cancer-specific and clinician-led
No listener should substitute the episode for oncology advice

“I'm not telling them that.”
Professor Thomas Seyfried · 1:05:00

“you don't have to get rid of a lot of these different procedures that we have today”
Professor Thomas Seyfried · 1:05:00

#chemotherapy#standard care#oncology#patient safety

Hot Take· 2

Hot Take07:00

Seyfried's Case for Cancer as a Metabolic Disease

Seyfried argues that cancers share a dependence on fermentation after impaired mitochondrial energy production, despite differing by tissue and genetics. This is his central scientific thesis; the episode does not establish that it has replaced the mainstream genetic model or that it applies without qualification to every cancer.

Seyfried places mitochondrial dysfunction upstream of uncontrolled growth
He says tumour cells rely heavily on glucose and glutamine fermentation
He treats many observed mutations as downstream effects
The transcript presents a disputed theory, not medical consensus

“they all have one thing in common. They depend on a on a fermentation energy without oxygen.”
Professor Thomas Seyfried · 07:30

#cancer metabolism#mitochondria#fermentation

Hot Take33:00

The Nuclear-Transfer Evidence Seyfried Uses Against a Gene-First Model

Seyfried cites cancer cells without mutations, driver mutations in normal tissue, and nuclear-transfer experiments as challenges to a purely gene-first account of cancer. He says tumour nuclei can show regulated growth in normal cytoplasm while normal nuclei show dysregulated growth in tumour cytoplasm. The transcript does not examine contrary evidence or the limits of those experiments.

Some cancers are described as having no identified mutations
Mutations associated with cancer can also occur in normal tissue
Seyfried places causal weight on the cell cytoplasm and mitochondria
Only one side of the scientific dispute is developed in the episode

“you put the tumor cell into that cytoplasm you get regulated growth”
Professor Thomas Seyfried · 35:00

#cancer genetics#nuclear transfer#mitochondria

Explainer· 4

Explainer08:00

How Seyfried Explains Fermentation in Cancer Cells

Seyfried contrasts efficient oxygen-dependent energy production in mitochondria with fermentation pathways that can produce energy without oxygen. He says cancer cells continue producing fermentation waste products even when oxygen is present, which he interprets as evidence of inefficient mitochondrial function.

Normal mitochondria use oxygen to extract energy from food
Cells can temporarily obtain energy without oxygen
Seyfried links glucose fermentation to lactic acid
He links glutamine fermentation to succinic acid
He interprets persistent fermentation as a sign of mitochondrial dysfunction

“Fermentation is energy without oxygen.”
Professor Thomas Seyfried · 08:00

#cell biology#fermentation#glucose#glutamine

Explainer17:30

The Two-Fuel Hypothesis Behind Seyfried's Metabolic Therapy

Seyfried proposes restricting glucose and targeting glutamine while shifting healthy tissues toward fatty acids and ketone bodies. He says normal cells can use ketones more effectively than tumour cells with damaged mitochondria. This is a treatment hypothesis described by the guest, not a self-treatment protocol or proof of clinical benefit.

The proposed tumour fuels are glucose and glutamine
Dietary restriction is intended to lower glucose availability
Seyfried says drugs are needed to target glutamine in treatment
Ketones are proposed as an alternative fuel for healthy cells
Clinical use requires specialist oversight and stronger evidence than supplied here

“simultaneously restrict the two fuels that are needed to drive this disregulated growth”
Professor Thomas Seyfried · 17:30

#metabolic therapy#ketones#glutamine#cancer treatment

Explainer42:00

Progression-Free Survival Is Not the Same as Living Longer

Seyfried distinguishes progression-free survival, where a tumour does not appear to worsen for a period, from overall survival, which measures how long patients live. He argues that drug approval can overemphasize the former even when gains in the latter are small. His claims about regulators and individual drugs are forceful and are not independently substantiated in the episode.

Progression-free survival tracks apparent disease progression
Overall survival tracks time alive
A treatment can improve one endpoint more than the other
Surrogate endpoints should not be mistaken for demonstrated longevity
The episode does not provide the underlying trial data

“You want overall survival.”
Professor Thomas Seyfried · 43:30

#clinical trials#survival#drug approval

Explainer1:07:30

Why Seyfried Pairs Ketosis With Hyperbaric Oxygen in Mice

Seyfried says nutritional ketosis may reduce two forms of protection available to tumour cells, while hyperbaric oxygen increases dissolved oxygen and reactive oxygen species. He proposes that the combination selectively stresses tumour cells while supporting healthy cells. The survival increase discussed by Bartlett refers to mice, and the episode does not establish equivalent safety or efficacy in human cancer patients.

The cited survival result comes from a mouse experiment
Hyperbaric treatment increases dissolved oxygen in blood
Seyfried proposes reactive oxygen species as the tumour-killing mechanism
He says ketosis is necessary for the intended selectivity
Animal results do not establish a human treatment protocol

“It works best when the patient and the mouse is in nutritional ketosis.”
Professor Thomas Seyfried · 1:08:00

#hyperbaric oxygen#ketosis#mouse study#reactive oxygen species

Story· 3

Story12:30

The Observations That Shifted Seyfried Toward Metabolism

Seyfried says Linda Nebeling's ketogenic-diet work with two children with brain cancer led him back to Otto Warburg's experiments. He describes Warburg observing lower oxygen use, greater glucose uptake, and lactate production in tumour tissue, then connects those observations to his own mouse research. The reported child cases and mouse findings do not by themselves establish treatment efficacy in humans.

Nebeling's cases prompted Seyfried to revisit Warburg
Warburg compared tumour tissue with corresponding normal tissue
Seyfried reports a relationship between blood glucose and tumour growth in mice
The episode moves from historical observation to a modern treatment hypothesis

“she gave them a ketogenic diet to lower blood sugar”
Professor Thomas Seyfried · 13:00

#otto warburg#ketogenic diet#research history

Story55:00

The Pit Bull Tumour Case—and Why One Case Is Not Proof

Seyfried recounts a pit bull with a mast-cell tumour whose owner changed the dog's diet and modestly reduced calories instead of pursuing the proposed conventional treatment. He says the tumour disappeared and the dog later died of heart disease at 15 and a half. He calls it apparent cure in that dog, but it remains a single owner-led case report without a controlled comparison.

The owner changed both food composition and calorie intake
Seyfried says the dog lost about five percent of its body weight
A veterinarian joined the eventual paper
The tumour reportedly disappeared
One case cannot establish efficacy or replace veterinary oncology

“in the case of that dog it appeared to work”
Professor Thomas Seyfried · 57:00

#case report#veterinary cancer#metabolic therapy

Story57:30

Pablo Kelly's Ten-Year Glioblastoma Story

Seyfried describes Pablo Kelly declining chemotherapy and radiation, following a low-carbohydrate metabolic approach, and undergoing three tumour-debulking operations over roughly ten years. Kelly died after a cerebral haemorrhage following surgery in 2024. The survival was unusual by Seyfried's account, but one exceptional, multi-intervention case cannot show that metabolic therapy caused the outcome or that others should copy his choices.

Kelly was diagnosed with glioblastoma in 2014
He used metabolic measures and repeated surgery
Seyfried says the initially inoperable tumour later became resectable
Kelly underwent three debulking procedures
The account is anecdotal and cannot determine treatment causation

“I've had now three operations on a previously inoperable tumor.”
Professor Thomas Seyfried quoting Pablo Kelly · 1:01:30

#glioblastoma#pablo kelly#case study#surgery

Takeaway· 3

Takeaway24:30

What Seyfried Claims Links Lifestyle to Mitochondrial Damage

Seyfried names inactivity, highly processed carbohydrates, emotional stress, poor sleep, and carcinogen exposure as pressures that may impair mitochondrial function over time. He recommends exercise and occasional fasting as protective practices, but his broad claim that these measures prevent cancer is stronger than the evidence presented in the transcript.

He describes cancer development as gradual rather than instantaneous
He associates exercise with lower blood sugar and better mitochondrial function
He names processed carbohydrates, stress, and poor sleep as risks
He acknowledges uncertainty around ubiquitous microplastics
Risk reduction is not a guarantee of prevention

“it is a gradual process”
Professor Thomas Seyfried · 26:00

“The problem is we are chronically abuse it without realizing what we need to do to keep it healthy.”
Professor Thomas Seyfried · 31:30

#lifestyle#cancer risk#exercise#sleep

Takeaway1:12:30

Fasting Can Raise Ketones, but the Episode Is Not a Prescription

Seyfried calls fasting a powerful way to enter nutritional ketosis and describes a 10-to-14-day zero-carbohydrate transition as easier than abruptly stopping food. He also says he is a scientist rather than a physician and declines to tell Bartlett what he should do. Prolonged fasting and restrictive diets can carry medical risks, and the transcript does not establish them as cancer prevention or treatment.

Fasting is presented as one route into nutritional ketosis
Seyfried describes a low-carbohydrate transition before fasting
He explicitly avoids prescribing a personal plan
Historical long fasts are examples, not safety guidance
Medical supervision matters for restrictive diets or fasting

“I don't want to tell you what you should or should not do. I'm not a physician here. I'm a scientist.”
Professor Thomas Seyfried · 1:13:00

#fasting#ketosis#medical disclaimer

Takeaway1:21:00

Seyfried's Own Routine Is Moderation, Not Metabolic Perfection

Seyfried says he sometimes eats doughnuts, pizza, and drinks alcohol because he enjoys them, while also exercising, intermittently fasting, and avoiding constant indulgence. His account undercuts an all-or-nothing reading of the conversation: he presents informed personal choice and occasional restriction, not continuous metabolic perfection.

Seyfried does not claim to follow a perfect ketogenic diet
He reports exercising and sometimes fasting for 18 to 20 hours
He distinguishes occasional enjoyment from a constant pattern
His personal routine is anecdotal, not a prevention prescription

“I'm eating a jelly donut. I'm drinking beer. I'm drinking whiskey. Why? Cuz I like it.”
Professor Thomas Seyfried · 1:21:30

#moderation#lifestyle#personal choice